<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NMRA
Neumora Therapeutics
$
()


  • Neumora Therapeutics initiated with bullish view at Needham, here's why

    7/22/2024 - 06:16am
  • Neumora Therapeutics initiated with bullish view at Mizuho, here's why

    7/8/2024 - 06:35am
  • Neumora Therapeutics announces initiation of Phase 1b study of NMRA-511

    6/20/2024 - 07:06am
  • Neumora initiates Phase 2 study of navacaprant in bipolar depression

    5/14/2024 - 07:17am
  • Neumora Therapeutics reports Q1 EPS (34c), consensus (34c)

    5/7/2024 - 07:08am
  • Fly Intel: Pre-market Movers

    4/15/2024 - 08:53am
  • Neumora Therapeutics falls 23% after FDA clinical hold of Phase 1 NMRA-266 study

    4/15/2024 - 06:47am
  • Neumora Therapeutics announces clinical hold of Phase 1 NMRA-266 study

    4/15/2024 - 06:32am
  • Neumora weakness amid lock-up expiration a buying opportunity, says RBC Capital

    3/13/2024 - 12:46pm
  • Neumora Therapeutics price target raised by $7 at RBC Capital, here's why

    3/8/2024 - 08:57am
  • Neumora Therapeutics reports Q4 EPS (71c), consensus (55c)

    3/7/2024 - 07:01am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:55am
  • JPMorgan biotech analysts to hold an analyst/industry conference call

    2/23/2024 - 11:00am
  • Neumora Therapeutics appoints Panandiker as Chief Commercial Officer

    1/22/2024 - 07:08am
  • The biopharmaceuticals stocks to own in 2024, according to BofA

    1/3/2024 - 10:47am
dynamic_feed Breaking News